Important notice. This is an analytical note, not investment advice, a recommendation, or an offer or solicitation of any security or fund interest. It evaluates a proposed public offering using Venture Science's multi-criteria decision analysis (MCDA) discipline and is published for informational purposes only.
AI assistance and conflict of interest. Portions of this analysis were prepared with assistance from Claude, an AI model developed by Anthropic, PBC, the issuer under review. The output has been edited for publication but has not been independently verified. Readers should weigh that conflict when assessing the note and should not rely on it.
Status of the information. Anthropic's Form S-1 was filed publicly on October 26, 2026 and is not yet effective. The number of shares, price range and offering size have not been set. Valuation, raise size and float figures cited below are press reports, not filed disclosures, and are labelled as such. Figures may be revised in amended filings. Full disclaimers appear at the end of this note.
Summary and analysis outlook
Analysis outlook: conditionally allocatable. On a consistent TOPSIS method, Anthropic scores a closeness coefficient of about 0.50 in the base case and about 0.35 if API pricing compresses 40% with usage flat. In Venture Science's framework, 0.40 is the house threshold below which an ECM allocation is not made. The offering clears it today, with no margin for a margin miss.
The case rests on three facts the filing establishes and one it does not:
- Growth is real and the operating business is near breakeven. First-half 2026 revenue was $16.3 billion against an operating loss of $693 million. Third-quarter revenue reported to investors was $16.8 billion, up 45% quarter over quarter.
- The $80.7 billion net loss is an accounting artifact. Roughly $72 billion is a non-cash fair-value charge on convertible instruments that grows as the private valuation rises. It will keep growing until the notes convert at the IPO, then largely disappear.
- Compute obligations are the balance sheet. Disclosed commitments run from at least $518 billion to roughly $637 billion over eight to ten years, about 80% non-cancelable. That is a $50–65 billion annual payment floor against roughly $67 billion of annualized revenue.
- Gross margin is still not pinned down. Pre-filing estimates clustered at 44–50%. The compute floor is survivable at 50% and not at 35%. This single number decides the investment case.
What this means in practice for an allocator: participate only at a discount to the reported $1.5–2 trillion range that compensates for a governance structure in which, as filed and reported, public holders control neither the board majority nor stockholder votes, size the position to the first lock-up window of 27 days rather than a conventional 180, and hedge. If the gross margin disclosed in the amended filing is below 40%, the position is not allocatable at any price in the reported range.
The offering as filed vs. as reported
Much of the public discussion mixes filed facts with press reporting. The distinction matters for scoring, so the table separates them.
| Item | Status | Detail |
|---|---|---|
| Issuer | Filed | Anthropic, PBC, a Delaware public benefit corporation |
| Listing | Filed | Nasdaq Global Select Market, ticker ANT, Class A common stock |
| Lead underwriters | Filed | Goldman Sachs, Morgan Stanley |
| Selling stockholders | Filed | Included alongside primary shares |
| Shares and price range | Filed | Not yet determined |
| Timing | Reported | Week of November 16, 2026; possibly November 19–20 (Investing.com) |
| Valuation | Reported | $1.5–2 trillion (Wall Street Journal, via Investing.com) |
| Raise | Reported | $100 billion or more |
| Implied float | Derived | ~5% at the reported figures; an input, not a disclosure |
| Last private round | Filed/reported | $65 billion at $965 billion, May 2026 (CNBC) |
| Lock-ups | Filed | Some employee and early-investor selling permitted on day one; releases at 27, 48, 62 and 76 days (CNBC) |
If the reported range holds, the IPO would price at roughly 1.5–2.1x the May private round, six months later.
Revenue quality and growth
Anthropic's revenue growth is without precedent among issuers of comparable scale, and the mix is healthier than a pure API story. The question the filing leaves open is what that revenue costs to produce.
| Metric | Value | Period / source |
|---|---|---|
| Revenue | $16.29 billion | H1 2026 (Jan–Jun), vs. $1.1–1.2 billion a year earlier (Investing.com) |
| Revenue | $16.8 billion | Q3 2026 (Jul–Sep), +45% vs. Q2, as told to investors (Dealroom) |
| Revenue | $4.59 billion | Full-year 2025 (Yahoo Finance) |
| Revenue growth | 1,368% YoY | Three months ended June 30, 2026 (Unite.ai) |
| Compute cost growth | 300% YoY | Same period |
| Net revenue retention | ~900% | Excludes Claude Pro and Max subscribers |
| Subscription revenue | $3.2 billion (20%) | H1 2026 (CNBC) |
| International revenue | $4.5 billion (27.8%) | H1 2026 |
What is strong
Revenue growing four to five times faster than compute cost is the operating-leverage signal the market has been waiting for from a frontier lab. A fifth of revenue from subscriptions and more than a quarter from outside the US reduce dependence on any single enterprise channel.
What is unresolved
- Gross margin. The filing says substantially all cost of revenue is compute and infrastructure. Pre-filing analyst estimates put gross margin near 44% (Morningstar) to roughly 50% (company projections shared with investors), with a stated path toward 77% by 2028. The audited figure in the amended filing will reset consensus in one direction or the other.
- Gross versus net. Channel partner fees paid to Amazon, Google and Microsoft for marketplace distribution are booked in sales and marketing ($3.8 billion in H1) rather than netted from revenue. Headline revenue is therefore not directly comparable with peers that report net of partner take.
Neither point undermines the growth. Both determine whether the growth can carry the compute obligations discussed below.
Profitability and the $80.7 billion loss
The headline loss is a valuation artifact, and the operating line is within rounding of breakeven. Readers should separate the two.
| Line item | H1 2026 | FY 2025 |
|---|---|---|
| Revenue | $16.29B | $4.59B |
| Operating costs | $16.98B | — |
| Operating loss | $693M | $8.06B |
| Research and development | $9.7B | — |
| Sales and marketing (incl. channel fees) | $3.8B | — |
| Compute and infrastructure spend | — | $7.33B |
| Fair-value charges on convertible instruments | $72.4B | — |
| Net loss | $80.75B | ~$42B |
Sources: IBTimes, Motley Fool, WION, Crypto Briefing.
Why the loss is so large
Anthropic raised capital through convertible notes and similar instruments carried at fair value. As the enterprise valuation rose from the 2025 rounds to $965 billion in May 2026, the liability was marked up and the increase ran through the income statement as a loss. The higher the private mark, the larger the GAAP loss: $72.4 billion of the $80.75 billion is this charge.
What happens next
Expect a further large charge in the second half of 2026 as marks move from $965 billion toward the reported IPO range. At the IPO the instruments convert to equity and the charge stops. The relevant run-rate for valuation is the operating line, which the company projected to investors would turn positive in the second quarter, and operating cash flow, reported as positive in coverage of the filing. Neither is yet confirmed by audited quarterly figures.
The caution
A business that is breakeven on $17 billion of half-year cost has no cushion. Every dollar of the compute floor in the next section comes out of a margin that does not yet exist in audited form.
Compute obligations: the core of the case
Anthropic has committed to between $518 billion and roughly $637 billion of compute, cloud and infrastructure spend over the next eight to ten years, most of it payable regardless of usage. This is the balance sheet, and it is the line on which the investment case turns.
Form S-1 text and reporting on it (Motley Fool, Fortune, CNBC) · as of October 26, 2026.
The filing's own contractual commitments table was left blank in the public version, so the counterparty figures above are drawn from the S-1 text and from reporting on it (Motley Fool, Fortune, SEC). Fortune tallies the total at $542–567 billion; earlier reporting on the draft put it at $518 billion. Beyond these, Anthropic has committed to procure an estimated $125–150 billion of additional TPU compute for 2028–2031 that sits outside the table.
Terms that matter
The Google and Amazon agreements are non-cancelable except for the provider's uncured material breach, and Anthropic must pay the shortfall if actual spend falls below the contracted amount. The SpaceX arrangements, by contrast, are mostly cancelable on 90 days' notice and carry a run-rate of about $3.1 billion a month once all capacity is delivered. That is the only large flexible tranche, and the first one that reprices if demand slows.
The arithmetic
Spread evenly, $518–637 billion over eight to ten years is a payment floor of roughly $50–65 billion a year. Annualized third-quarter revenue is about $67 billion. At a 50% gross margin, today's revenue covers the floor with little to spare. At a 35% gross margin, or with a 40% price cut that is not offset by volume, it does not. Rating agencies and credit analysts will treat the non-cancelable portion as a debt equivalent, and so does this framework.
Mitigants the bear case understates
Usage, not price, has driven revenue so far, and the orchestration layer the filing describes lets Anthropic shift workloads across Trainium, TPU, Nvidia and AMD silicon. Vendor financing is substantial: Amazon has agreed to provide up to $15 billion in $5 billion tranches, Broadcom up to $42 billion and Google $20 billion in potential financing. These reduce near-term liquidity risk; they do not reduce the obligation.
Circularity and counterparty dependence
Anthropic's three largest cloud counterparties are simultaneously its investors, its suppliers, its distribution channels and its competitors. The filing says so directly, naming Amazon, Google and Microsoft as competitors that develop and deploy rival models through their own cloud platforms, and describing the compute relationships as creating dependencies and potential vulnerabilities (CNBC).
| Counterparty | Roles with Anthropic |
|---|---|
| Amazon | Investor, primary cloud and training partner, Trainium supplier, marketplace channel, up to $15 billion lender, competitor |
| Investor, TPU supplier, $20 billion potential financier, marketplace channel, competitor | |
| Microsoft | Compute supplier ($44.9 billion), marketplace channel, competitor |
| Broadcom | TPU capacity supplier ($161.2 billion), up to $42 billion potential financier |
| SpaceX | GPU capacity supplier; 34.5% of SpaceX's Q3 revenue came from a customer identified as Anthropic (Traders Agency) |
Three consequences follow for an allocator:
- The leases are not arm's-length. A supplier that is also a shareholder has reasons to extend terms in a downturn, which softens the compute floor, and reasons to prioritise its own models, which hardens it. Neither is priced in a conventional lease analysis.
- Channel economics are opaque. Marketplace fees to the same three companies sit in sales and marketing. Whether those fees are fixed or scale with revenue determines how much operating leverage the business really has.
- The dependence runs both ways. SpaceX now relies on Anthropic for a third of its revenue. Concentration of this kind tends to stabilise relationships in good times and to transmit stress quickly in bad ones.
Governance: four share classes, two control layers
If the reported founder share class is adopted as described, public Class A holders will have a decisive vote on neither the board majority nor most stockholder matters. That is a more complete exclusion than SpaceX's dual-class structure, though with a different purpose and different safeguards.
| Class | Holder | Rights |
|---|---|---|
| Class A | Public and existing investors | One vote per share on matters generally, including election of directors other than Class T directors |
| Class N | Existing holders (participating common) | Economic participation; voting as set out in the charter |
| Class T | Long-Term Benefit Trust (LTBT) | Elects the Class T directors; Trust-appointed directors have been a board majority since April 2026 |
| Class F | Founder LLC (the seven co-founders) | Reported to carry a combined 50.1% of votes on most corporate matters; holds only while at least three founders keep an undisclosed minimum stake |
| Class E | Employees other than co-founders | Terms per the charter |
Sources: SEC Form S-1, TechCrunch via AI Weekly, iTechGuides.
The two layers
The Trust controls who sits on the board. The founders, through Class F, control the outcome of stockholder votes. Neither group is answerable to Class A. Because the Trust can elect a board majority, Anthropic qualifies as a controlled company under Nasdaq rules (Unite.ai).
What mitigates it
The filing states the company expects to rely only on the nominating-committee exemption, and that the board has a majority of independent directors with fully independent audit and compensation committees. LTBT trustees hold no equity and do not share in profits (WSJ via iTiger). Control is therefore split across a non-economic trust and seven founders who each own roughly 2%, rather than concentrated in one person. The public benefit purpose, responsibly developing advanced AI for humanity's long-term benefit, is a statutory obligation to balance, not a licence to ignore stockholders.
What does not
The trust agreement and its arrangements with the company are not public, including when and how stockholders could override the Trust. Class F is new and its sunset terms are undisclosed. Proxy advisers will flag both. Index eligibility should be checked against each provider's current multi-class rules rather than assumed.
The framework scores governance at 1.5 of 5: a structural discount that no amount of revenue growth offsets, partly relieved by the independence of the committees that oversee the numbers.
Float, lock-ups and the SpaceX precedent
The one live comparable for a mega-cap listing with a ~5% float is SpaceX, and it argues that any scarcity premium at the Anthropic open will be short-lived.
SpaceX, June 2026
SpaceX priced its IPO at $135, raised roughly $75–86 billion, opened at $150 and rose about 19% on day one (Nemo, The Edge). The stock peaked above $225 on June 17, then fell to the $135 IPO price by July 15 with only about 4% of shares trading (AI Weekly). By mid-2026 it had traded roughly 36% below its post-listing high. The premium lasted about five weeks.
Why Anthropic's supply picture is tighter, not looser
- Some employee and early-investor selling is permitted on the first day of trading.
- Lock-up releases follow at 27, 48, 62 and 76 days, rather than a single 180-day release (CNBC).
- Selling stockholders are part of the offering, so the primary raise is not the only source of float.
On a mid-November pricing, the four releases land between mid-December and early February, the same window in which the fourth-quarter fair-value charge and the first public earnings report arrive.
The implication
The usual trade (accept full allocation, let the squeeze run, collar the position) still applies. But the collar should be sized to the first lock-up window of 27 days, not to the conventional 180, and any thesis that counts the lock-up structure as a stabiliser has it backwards.
Anchors
Press accounts of a $10 billion Nvidia commitment and a $5 billion Microsoft commitment refer to the 2025 financing at a ~$350 billion valuation, not to the IPO book (MarketScreener). No IPO cornerstone investors have been disclosed in the filing.
Valuation context
At the reported $2 trillion, Anthropic would price at roughly 30 times annualized third-quarter revenue, about where SpaceX priced on its own run-rate in June. The multiple is defensible only on the growth rate, and the growth rate is the input most exposed to pricing.
| Reference point | Figure | Implied multiple at $2T |
|---|---|---|
| Annualized Q3 2026 revenue | ~$67B | ~30x |
| Run-rate revenue the company has cited | >$47B | ~43x |
| 2028 revenue projection shared with investors | ~$70B | ~29x |
| 2028 cash flow projection shared with investors | ~$17B | ~118x |
Projections per Futurum; run-rate per WION. Projections are management figures reported in the press, not filed guidance.
A reverse-DCF framing
For $2 trillion to be fair value at a 25x terminal free-cash-flow multiple, the business needs about $80 billion of annual free cash flow. At a 25% free-cash-flow margin, that is roughly $320 billion of revenue, more than four times the 2028 projection. Investors paying the reported range are therefore underwriting either a decade of sustained hyper-growth beyond 2028, or a margin structure well above anything a compute-intensive business has yet shown.
The price-compression test
The sensitivity in Appendix C models a 40% cut to API pricing with usage flat. That is the open-source-commoditisation scenario. Under it, revenue quality falls from a score of 4.2 to 2.8 and balance-sheet durability from 1.6 to 1.3, because the compute floor is fixed while revenue is not. The closeness coefficient drops below the 0.40 house threshold.
What a discount should compensate for
Two structural deficits are permanent at any price: the governance exclusion of Class A, and the debt-equivalent compute floor. Venture Science's framework asks for an entry discount of 15–20% to the reported range to offset them, which at the top of the range implies roughly $1.6–1.7 trillion. That is a framework output, not a prediction of where the deal prices.
Scorecard and conclusion
On the corrected facts and a consistent method, Anthropic scores 2.74 of 5.00 on weighted utility and a TOPSIS closeness coefficient of 0.498 in the base case. The 40% price-compression case falls to 0.347.
| Criterion | Weight | Score (1–5) | Weighted |
|---|---|---|---|
| C1 Revenue quality and margin durability | 0.35 | 4.2 | 1.470 |
| C2 Capital structure and float | 0.25 | 2.6 | 0.650 |
| C3 Corporate governance | 0.25 | 1.5 | 0.375 |
| C4 Balance sheet durability | 0.15 | 1.6 | 0.240 |
| Weighted utility | 1.00 | 2.735 | |
| Closeness coefficient, base case | 0.498 | ||
| Closeness coefficient, −40% API pricing | 0.347 |
Reading the result
A closeness coefficient near 0.50 means the offering sits roughly equidistant from the ideal and the worst-case profile in this framework. It is allocatable under Venture Science's 0.40 house threshold, but the margin is small and rests on one undisclosed number. Below 0.40 the framework does not allocate; the price-compression case lands there.
Conditions for participation
- Audited gross margin in the amended filing at or above 40%. Below it, the position is not allocatable in the reported range.
- An entry price that discounts the reported range by enough to compensate for the governance exclusion and the compute floor.
- Position sizing and hedging calibrated to the 27-day first lock-up release, not a 180-day assumption.
- A re-score when the contractual commitments table, the trust agreement terms and the Class F sunset provisions are disclosed.
What would move the outlook upward
A disclosed gross margin above 50%, confirmation that marketplace fees are largely fixed, or a cornerstone book that materially extends the effective lock-up.
What would change it downward
Evidence of API price compression in the third-quarter numbers, a contractual commitments total above the $637 billion upper bound used here, or any provision allowing the Trust or founders to block a change of control without a stockholder vote.
Appendix A: MCDA methodology
The framework combines three standard multi-criteria methods: the Analytic Hierarchy Process (AHP) to set criterion weights, Multi-Attribute Value Theory (MAVT) to convert disclosures into utility scores, and TOPSIS to express the result as a distance from ideal and worst-case profiles.
Step 1: AHP weighting
Criteria are compared pairwise on Saaty's 1–9 scale and the principal eigenvector of the comparison matrix gives the weights. For mega-cap technology offerings the hierarchy and weights are:
| Criterion | Weight | Sub-criteria (local weights) |
|---|---|---|
| C1 Revenue quality and margin durability | 0.35 | C1.1 Trailing revenue velocity (0.15) · C1.2 Forward visibility (0.12) · C1.3 Pricing power vs. open source (0.08) |
| C2 Capital structure and float | 0.25 | C2.1 Free float relative to market cap (0.10) · C2.2 Anchor and strategic conviction (0.08) · C2.3 Lock-up architecture (0.07) |
| C3 Corporate governance | 0.25 | C3.1 Voting-class disenfranchisement (0.12) · C3.2 Public-benefit mandate friction (0.08) · C3.3 Board independence (0.05) |
| C4 Balance sheet durability | 0.15 | C4.1 Adjusted free cash flow (0.08) · C4.2 Off-balance-sheet capital intensity (0.07) |
Sub-criteria weights sum to their parent's weight. A consistency ratio below 0.10 is required for the pairwise matrix to be accepted. The underlying pairwise matrix and its consistency ratio are maintained in Venture Science's scoring workbook and are not reproduced here.
Step 2: MAVT scoring
Each criterion receives a utility score from 1.0 (critical risk) to 5.0 (ideal quality), anchored to the filing. Sub-criteria are scored first and aggregated by their local weights. Appendix B gives the rationale.
Step 3: TOPSIS
Each score is multiplied by its weight to give a weighted value vector V. The positive ideal solution (PIS) is the vector of weights × 5.0; the negative ideal solution (NIS) is weights × 1.0. Euclidean distances to each are computed and the closeness coefficient is:
A coefficient of 1.0 is the ideal profile; 0.0 is the worst case. Because the weights differ across criteria, the coefficient is not a linear function of the weighted utility sum: a weak score on a heavily weighted criterion pulls the coefficient down faster than the simple average would suggest.
House threshold
Venture Science treats a closeness coefficient below 0.40 as non-allocatable for an unhedged long position in an equity capital markets transaction. This is a firm policy, not an industry standard.
Appendix B: Scoring rationale by criterion
Scores are anchored to the public S-1 and to reporting on it as of October 26, 2026. Where the filing leaves a figure blank, the score reflects the best available reporting and is flagged for re-scoring.
| Sub-criterion | Score | Anchor | Rationale |
|---|---|---|---|
| C1.1 Trailing revenue velocity | 4.8 | 1,368% YoY growth for the June 2026 quarter; Q3 +45% QoQ | Without precedent at this scale. Capped below 5 only because the base period is small |
| C1.2 Forward visibility | 4.0 | NRR ~900%; 20% subscription; 27.8% international | Strong, but NRR excludes consumer tiers and is a cohort metric, not a backlog |
| C1.3 Pricing power vs. open source | 3.4 | Gross margin estimated 44–50%; gross-vs-net channel accounting | The single largest open item. Scored at the midpoint pending the audited figure |
| C1 aggregate | 4.2 | ||
| C2.1 Free float relative to market cap | 2.4 | ~5% implied; shares and price not set | Thin float limits liquidity; SpaceX precedent shows the premium decays in weeks |
| C2.2 Anchor and strategic conviction | 3.4 | Vendor financing from Amazon, Broadcom, Google; no IPO cornerstones disclosed | Strategic alignment is real but is supplier alignment, not demand for the stock |
| C2.3 Lock-up architecture | 2.0 | Day-one selling permitted; releases at 27/48/62/76 days | Supply overhang begins immediately; a negative, not a stabiliser |
| C2 aggregate | 2.6 | ||
| C3.1 Voting-class disenfranchisement | 1.2 | Class T elects board majority; Class F reported at 50.1% of votes | Class A controls neither layer |
| C3.2 Public-benefit mandate friction | 1.6 | Delaware PBC; statutory duty to balance | Mission may be prioritised over return; the duty is to balance, not to ignore |
| C3.3 Board independence | 2.0 | Majority independent; fully independent audit and compensation committees | Real mitigant for financial oversight; nominating committee exemption used |
| C3 aggregate | 1.5 | ||
| C4.1 Adjusted free cash flow | 2.0 | Operating loss $693M on $16.3B revenue; operating cash flow positive | Breakeven with no cushion |
| C4.2 Off-balance-sheet capital intensity | 1.2 | $518–637B commitments, ~80% non-cancelable; contractual table blank | Debt-equivalent of 8–10x annual revenue |
| C4 aggregate | 1.6 |
Changes from the preliminary scoring
An earlier internal draft scored C2 at 3.2 and C4 at 2.0, on the assumption of a $245 billion compute commitment, a single 180-day lock-up and a Nvidia anchor in the IPO book. The public filing established commitments at least twice that size, a staggered lock-up with day-one selling, and no disclosed cornerstones. C3 moved from 1.4 to 1.5 to credit the independent committees, offset by the founder class.
Appendix C: TOPSIS computation and sensitivity
All three cases below use the same distance method, so the coefficients are comparable with one another.
Ideal and worst-case vectors
With weights (0.35, 0.25, 0.25, 0.15), the positive ideal solution is PIS = (1.750, 1.250, 1.250, 0.750) and the negative ideal solution is NIS = (0.350, 0.250, 0.250, 0.150).
Base case
| Criterion | Weight | Score | V = w × u | (PIS − V)² | (V − NIS)² |
|---|---|---|---|---|---|
| C1 | 0.35 | 4.2 | 1.470 | 0.0784 | 1.2544 |
| C2 | 0.25 | 2.6 | 0.650 | 0.3600 | 0.1600 |
| C3 | 0.25 | 1.5 | 0.375 | 0.7656 | 0.0156 |
| C4 | 0.15 | 1.6 | 0.240 | 0.2601 | 0.0081 |
| Sum | 2.735 | 1.4641 | 1.4381 |
Sensitivity: 40% API price compression, usage flat
Revenue quality falls to 2.8 as top-line growth decelerates mechanically; balance-sheet durability falls to 1.3 because the compute floor is fixed while revenue is not. Capital structure and governance are unchanged.
| Criterion | Weight | Score | V = w × u | (PIS − V)² | (V − NIS)² |
|---|---|---|---|---|---|
| C1 | 0.35 | 2.8 | 0.980 | 0.5929 | 0.3969 |
| C2 | 0.25 | 2.6 | 0.650 | 0.3600 | 0.1600 |
| C3 | 0.25 | 1.5 | 0.375 | 0.7656 | 0.0156 |
| C4 | 0.15 | 1.3 | 0.195 | 0.3080 | 0.0020 |
| Sum | 2.200 | 2.0265 | 0.5745 |
Comparison with the preliminary scoring
The earlier internal draft reported a base-case coefficient of 0.488 and a stress-case coefficient of 0.378. The 0.488 was the normalised weighted utility, (2.955 − 1) / 4, not a TOPSIS distance; computed on the same distance method as the stress case, the preliminary base case is 0.534. The table below restates all three on one method.
| Case | C1 | C2 | C3 | C4 | Weighted utility | CC* (consistent) |
|---|---|---|---|---|---|---|
| Preliminary base | 4.3 | 3.2 | 1.4 | 2.0 | 2.955 | 0.534 |
| Preliminary stress (−40% pricing) | 2.8 | 3.2 | 1.4 | 1.3 | 2.325 | 0.378 |
| Revised base | 4.2 | 2.6 | 1.5 | 1.6 | 2.735 | 0.498 |
| Revised stress (−40% pricing) | 2.8 | 2.6 | 1.5 | 1.3 | 2.200 | 0.347 |
Break-even on the house threshold
Holding C2, C3 and C4 at revised base-case levels, the coefficient crosses 0.40 when C1 falls to roughly 3.3. In the framework's terms, that corresponds to an audited gross margin in the high-30s with no offsetting volume response, the number flagged in the summary as the condition for participation.
Appendix D: Limitations of the framework
The framework is a disciplined way of making judgments explicit. It does not remove them. Readers should weigh the following.
- Single-alternative TOPSIS is a benchmark score, not a ranking. TOPSIS is designed to rank several alternatives against each other. With one issuer and synthetic ideal and worst-case vectors, it reduces to a weighted distance score. A full application would score Anthropic alongside a peer set: SpaceX as the listed comparable, OpenAI once it files, and capital-intensive infrastructure names such as CoreWeave as the bear-case reference.
- The weights overlap on compute. Pricing power (C1.3), adjusted free cash flow (C4.1) and off-balance-sheet intensity (C4.2) respond to the same underlying risk. The price-compression scenario therefore registers in three places. The result is directionally right but the magnitude of the swing is partly an artefact of the hierarchy.
- Scores are anchored to incomplete disclosure. The public filing leaves the contractual commitments table, share count and price range blank. Counterparty figures are drawn from the filing's narrative text and press reporting on it. The trust agreement and Class F terms are undisclosed. Every score touching those items is provisional.
- Projections are management figures reported second-hand. The 2028 revenue and cash-flow projections, and the gross-margin path, were shared with investors and reported in the press. They are not filed guidance and should not be read as such.
- The house threshold is a policy choice. The 0.40 cut-off reflects Venture Science's risk tolerance for unhedged ECM positions. Other allocators will set it elsewhere.
- AI assistance. The analysis was prepared with assistance from an AI model developed by the issuer. The facts were checked against the cited sources, but the content has not been independently verified, no responsibility is accepted for its accuracy or completeness, and the conflict is disclosed at the top of this note.
Sources
Primary
Reporting on the filing
- CNBC — Anthropic IPO live updates
- Investing.com — Anthropic files for IPO
- Investing.com — mid-November IPO timing
- Fortune — compute strategy in the S-1
- Motley Fool — five key numbers from the S-1
- Unite.ai — S-1 structure and controlled-company status
- IBTimes — loss breakdown
- WION — revenue, operating loss and run-rate
- Traders Agency — counterparty dependencies and SpaceX concentration
- Dealroom — draft S-1 summary
- Crypto Briefing — 2025 figures
- Yahoo Finance — the $518 billion commitment
- BigGo — SpaceX compute terms
Governance
- TechCrunch via AI Weekly — founders' 50.1% voting class
- Reuters via The Star — supervoting shares
- WSJ via iTiger — the Long-Term Benefit Trust
- iTechGuides — ownership and Trust-appointed board majority
Margins and projections
Comparable: SpaceX
Disclaimers
No offer or solicitation. This note is published by Palo Alto Venture Science LLC ("Venture Science") for informational and educational purposes only. Nothing in it constitutes an offer to sell, or a solicitation of an offer to buy, any security, including interests in Venture Science Strata Fund LP or any other vehicle managed or advised by Venture Science. Any such offer will be made only through a confidential private placement memorandum and related subscription documents, and only to persons who meet the applicable eligibility requirements.
Not investment, legal, tax or accounting advice. The analysis reflects the opinions of Venture Science as of the date shown and is not a recommendation to buy, sell, hold or participate in any security or offering. It does not take into account the investment objectives, financial situation or needs of any reader. Readers should consult their own advisers before making any investment decision.
No position statement. This note does not state or imply whether Venture Science or any fund it manages holds, intends to acquire, or will participate in any security of Anthropic, PBC, SpaceX, or any other company named. Venture Science and its affiliates may hold or transact in securities of companies mentioned, or of their investors, suppliers or competitors, and may change those positions without notice.
Registration status. Venture Science is an exempt reporting adviser with the U.S. Securities and Exchange Commission. Exempt reporting adviser status does not imply a certain level of skill or training, nor SEC endorsement or approval.
Sources and accuracy. Information is drawn from Anthropic's Form S-1 as publicly filed on October 26, 2026, and from press reporting on that filing and on comparable transactions, each cited in the text. Venture Science has not independently verified third-party information and makes no representation as to its accuracy or completeness. The registration statement is not yet effective and may be amended; figures cited here may change. Certain figures described as reported, estimated, projected or derived are not filed disclosures and are labelled as such.
Forward-looking statements. Statements about expected pricing, timing, margins, cash flows, lock-up behaviour, index treatment or market reaction are forward-looking, involve known and unknown risks and uncertainties, and may prove wrong. Venture Science undertakes no obligation to update them.
Framework outputs. Scores, weights, closeness coefficients and thresholds are outputs of Venture Science's proprietary multi-criteria decision analysis framework. They reflect judgments that other analysts would make differently and are subject to the limitations described in Appendix D. They are not valuations, price targets or predictions.
Past performance. References to the trading history of SpaceX or any other security are provided as context only. Past performance is not indicative of future results. Investing in initial public offerings and in early-stage or venture-backed companies involves substantial risk, including the possible loss of the entire investment, and is suitable only for investors who can bear that risk.
Fund interests. Interests in the Fund are speculative and involve a high degree of risk, including the potential loss of the entire investment and a lack of liquidity. Such interests have not been registered under the U.S. Securities Act of 1933, the Investment Company Act of 1940, or any state securities laws.
Eligibility. Any offering of interests in Venture Science Strata Fund LP is made privately under Regulation D and only to eligible investors: Accredited Investors (Qualified Client verification required for the performance allocation) and Qualified Purchasers.
Technology risk. Investments in technology companies are subject to significant risks, including rapid technological change, product obsolescence, intense competition, regulatory uncertainty, and dependence on key personnel and intellectual property. Technology companies may experience significant price volatility, and there can be no assurance that products or services will achieve market acceptance or generate sustainable revenue. The Fund's concentration in technology sectors may result in greater volatility than more diversified investment strategies.
Artificial intelligence risk. Artificial intelligence represents exposure to a nascent and rapidly evolving technology. AI investments carry risks including regulatory scrutiny related to data privacy, algorithmic bias, and safety concerns, as well as uncertainty regarding the commercial viability of AI applications. The sector is characterized by high research and development costs, uncertain paths to profitability, and competition from well-capitalized technology incumbents.
No warranty. The Fund, the General Partner, and their affiliates make no representations or warranties, express or implied, regarding the accuracy, completeness, or reliability of any data, figures, or other information contained herein. Such information may be based on third-party sources, estimates, or projections that have not been independently verified. The Fund and its affiliates expressly disclaim any liability for errors, omissions, or inaccuracies, and readers should not rely solely on this note when making investment decisions.
AI assistance. Portions of this note were prepared with the assistance of Claude, an AI model developed by Anthropic, PBC, the issuer analysed. The content has been edited for publication but has not been independently verified, and Venture Science accepts no responsibility or liability for its accuracy, completeness or any use made of it. Anthropic had no role in, and has not reviewed or approved, this note.
Trademarks. VENTURE SCIENCE is a registered trademark of Palo Alto Venture Science LLC in the United States. Other names are the property of their respective owners and are used for identification only.
Notice for Turkey. This note does not, and is not intended to, constitute any activity targeting marketing, offering or extending an invitation to purchase any securities, shares or any other negotiable or non-negotiable, financial or capital market instruments of any kind. This note is therefore not intended and may not be distributed within the Republic of Turkey neither within the meaning and scope of Communiqué on Foreign Capital Market Instruments and Depositary Receipts and Foreign Investment Funds numbered VII-128.4 nor Decree No. 32 on the Protection of the Value of Turkish Currency. This note does not constitute a prospectus as per Art. 3(j) of the Turkish Capital Market Code or any other document prescribed in Turkish Capital Market Code or its communiqués for a similar purpose, and has been prepared without regard to the disclosure standards for issue prospectuses or listing prospectuses under Turkish Capital Markets Law or the listing rules of any other stock exchange or regulated trading facility in Turkey. The shares will not be listed on the Borsa Istanbul or on any other stock exchange or regulated trading facility in Turkey.
© 2026 Palo Alto Venture Science LLC. All rights reserved.